Actively Recruiting
The Safety and Efficacy Evaluation of Echocardiography-guided Percutaneous Radiofrequency Ablation for Cardiac Tumors: a Single-arm, Prospective, Single-center Clinical Study
Led by Xijing Hospital · Updated on 2025-02-17
40
Participants Needed
1
Research Sites
153 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The safety and efficacy evaluation of echocardiography-guided percutaneous radiofrequency ablation (Liwen prcocedure) for cardiac tumors: a single-arm, prospective, single-center clinical study.
CONDITIONS
Official Title
The Safety and Efficacy Evaluation of Echocardiography-guided Percutaneous Radiofrequency Ablation for Cardiac Tumors: a Single-arm, Prospective, Single-center Clinical Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cardiac tumors causing hemodynamic changes or obvious symptoms such as chest tightness, shortness of breath, or palpitations, or risk of embolization
- Patients who cannot be fully treated by surgery, cannot tolerate surgery, or refuse surgery
- Informed consent provided and agreement to complete all study requirements and follow-up
You will not qualify if you...
- History of persistent ventricular tachycardia, ventricular fibrillation, supraventricular tachycardia with hemodynamic disturbance, cardiac arrest, or high atrioventricular block
- Previous tumor or thromboembolism causing organ embolism
- Other heart diseases requiring surgery
- Active infection requiring antibiotic treatment
- Bleeding disorders or contraindications to anticoagulation or antiplatelet therapy
- Pregnancy, breastfeeding, or planning pregnancy during the study
- Conditions interfering with treatment evaluation such as mental illness or metabolic disease
- Unable to tolerate general anesthesia
- Severe failure of major organs such as liver, kidney, lung, or brain
- No suitable injection path for the Liwen procedure
- Any other medical conditions deemed unsuitable by researchers
- Poor patient compliance making study completion unlikely
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xijing Hospital
Xi'an, Shannxi, China, 710032
Actively Recruiting
Research Team
L
Liwen Liu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here